Skip to search formSkip to main contentSkip to account menu

Tamoxifen Citrate

Known as: (Z)-2-[4-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethanamine 2-Hydroxy-1,2,3-propanetricarboxylate (1:1), 1-p-beta-dimethylamino-ethoxyphenyl-trans-1,2-diphenylbut-1-ene Citrate, Tamoxifen Citrate [Chemical/Ingredient] 
The citrate salt of an antineoplastic nonsteroidal selective estrogen receptor modulator (SERM). Tamoxifen competitively inhibits the binding of… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2006
Review
2006
BACKGROUND Although tamoxifen citrate has been approved for primary reduction of breast cancer risk since 1998, little is known… 
2004
2004
Abstract4-OH-tamoxifen is an active metabolite of tamoxifen that is detectable in the serum and tumour tissue of patients treated… 
2004
2004
The non-steroidal antiestrogen tamoxifen (TAM) is successfully used to treat all stages of breast cancer in both pre- and… 
Highly Cited
1999
Highly Cited
1999
BACKGROUND A prospective phase 2 study of daily oral tamoxifen citrate in young adults with recurrent anaplastic astrocytomas… 
Highly Cited
1992
Highly Cited
1992
The chemopreventive efficacies of the retinoid all-trans-N-(4-hydroxyphenyl)-retinamide (4-HPR) and the anti-estrogen tamoxifen… 
Highly Cited
1984
Highly Cited
1984
We have used a covalently attaching antiestrogen, tamoxifen aziridine [TA; (Z)-(1-[4-(2-[N-aziridinyl] ethoxy)phenyl])1,2… 
1982
1982
The biochemical and morphological effects on the immature rat uterus of tamoxifen citrate (TAM) and LY117018 were compared with…